Welcome to our dedicated page for Enhabit SEC filings (Ticker: EHAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Enhabit's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Enhabit's regulatory disclosures and financial reporting.
Enhabit, Inc. General Counsel and Secretary Dylan C. Black reported routine equity compensation and related tax withholding transactions in company common stock. On March 6, 2026, he acquired 10,030 shares at $13.6100 per share through a grant or award. On the same date, 3,747 shares were disposed of at $13.6100 per share to cover tax obligations tied to restricted stock vesting. On March 7, 2026, an additional 2,422 shares were similarly withheld for taxes at $13.6100 per share. After these transactions, he directly owned 88,360 shares of Enhabit common stock.
Enhabit, Inc. filed its annual report outlining a large, national home health and hospice platform and the growing regulatory and reimbursement complexity it faces. The company operated 249 home health and 117 hospice locations across 34 states as of December 31, 2025, with Home Health generating $813.8 million of net service revenue and Hospice $246.2 million. Medicare and Medicare Advantage together supplied 89.7% of net service revenue, reflecting a steady shift from traditional Medicare to Medicare Advantage. Enhabit highlights clinical quality metrics that beat national averages and a payer innovation strategy focused on value‑based contracts. The filing also describes a proposed all‑cash merger with a Kinderhook affiliate valued at approximately $1.1 billion and details extensive risks that the transaction may be delayed, altered, or not completed.
Enhabit, Inc. reported solid fourth quarter and full-year 2025 results while highlighting its pending sale to Kinderhook Industries for $13.80 per share in cash, valuing the company at about $1.1 billion. Fourth quarter net service revenue was $270.4 million, up 4.7% year over year, with consolidated Adjusted EBITDA rising 11.6% to $28.0 million and Adjusted EBITDA margin improving to 10.4%.
The company still posted a GAAP net loss attributable to Enhabit of $38.7 million, or diluted loss per share of $0.76, driven in part by $47.7 million of goodwill and intangible asset impairments, but generated adjusted diluted EPS of $0.14. For 2025, revenue reached $1.06 billion, up 2.4%, and Adjusted EBITDA grew 8.4% to $108.5 million.
Home health net service revenue increased 3.2% in the quarter, with total admissions up 7.3% and cost per patient day down 3.5% year over year, while hospice revenue rose 10.0% on 9.9% growth in average daily census. Enhabit continued to strengthen its balance sheet, reducing total bank debt by $125.0 million since the end of 2023, achieving a 3.7x leverage ratio and realizing about $22 million in annualized cash interest savings. Adjusted free cash flow for 2025 was $71.2 million, up from $53.5 million in 2024. The Kinderhook merger is expected to close in the second quarter of 2026, subject to stockholder approval and customary conditions, and Enhabit has suspended earnings calls and financial guidance while the transaction is pending.
Enhabit, Inc. entered into an amended and restated credit agreement providing a $315 million Term Loan A Facility and a $160 million Revolving Credit Facility, both maturing five years from closing. Interest is based on SOFR or an alternate base rate plus a margin tied to Enhabit’s total net leverage ratio, with initial margins of 2.25% over SOFR and 1.25% over the base rate.
The term loan amortizes 7.50% per year in equal quarterly installments starting June 30, 2026, with the balance due at maturity. The revolving facility includes a $40 million letter of credit sublimit. Proceeds refinance Enhabit’s prior credit agreement, pay related fees and expenses, and support general corporate purposes.
The facilities are guaranteed by certain existing and future wholly owned domestic material subsidiaries and secured by first-priority liens on substantially all assets of Enhabit and the guarantors. Key financial covenants include a maximum total net leverage ratio of 4.50 to 1.00, with a permitted 0.50 step-up for specified material acquisitions, and a minimum fixed charge coverage ratio of 1.25 to 1.00.
Enhabit, Inc. General Counsel and Secretary Dylan C. Black reported equity compensation activity and related tax withholding in company stock. On February 27, 2026, he acquired 19,228 shares of common stock as a grant or award at $13.58 per share, tied to performance-based restricted stock units covering a three-year period from 2023 to 2025. On February 27 and March 1, shares totaling several thousand were disposed of at prices around $13.58–$13.61 per share under code F transactions, which the footnotes explain were shares withheld or surrendered to cover his tax withholding obligations upon vesting. After the most recent tax-withholding disposition on March 1, 2026, he directly owned 84,499 shares of Enhabit common stock.
Enhabit, Inc. Chief Human Resources Officer Marion Tanya Renee reported equity compensation activity and related tax withholding in company stock. On February 27, 2026, she acquired 14,425 shares of common stock at $13.58 per share through a grant or award.
That same day, 5,928 shares were withheld at $13.58 per share to cover tax obligations tied to vesting of performance-based restricted stock units for the 2023–2025 period. On March 1, 2026, additional tax-withholding dispositions of 1,040 shares and 1,976 shares occurred at $13.61 per share. Following these transactions, she directly held 89,291 shares of common stock, with a further 1,712 shares held indirectly by her spouse.
Enhabit, Inc. executive Julie Diane Jolley reported equity compensation activity in the form of restricted stock vesting and related tax withholding. On February 27, 2026, she acquired 21,430 shares of common stock from performance-based restricted stock units, while several smaller blocks of shares were withheld at prices around $13.58–$13.61 per share to satisfy tax obligations.
Enhabit, Inc. President and CEO Barbara Ann Jacobsmeyer reported several equity compensation transactions involving the company’s common stock. On February 27, 2026, she acquired 117,671 shares through the vesting of performance-based restricted stock units covering the 2023–2025 period. On the same date and on March 1, 2026, she disposed of multiple blocks of shares (including 46,504, 4,591 and 14,993 shares) as tax-withholding dispositions, where shares were withheld or surrendered to cover tax obligations related to the vesting rather than sold in open-market trades. Following these transactions, she continued to hold a substantial direct ownership position in Enhabit common stock as reflected in the reported post-transaction share balances.
Enhabit, Inc. executive Jeanne Louise Kalvaitis, EVP of Hospice Operations, reported equity award activity and related tax withholding transactions in common stock. On February 27, 2026, she acquired 9,824 shares through a grant/award at $13.58 per share, tied to performance-based restricted stock units.
On February 27 and March 1, 2026, a total of 4,055 shares were disposed of at per‑share prices of $13.58 and $13.61 to satisfy tax withholding obligations on vested restricted stock, rather than through open‑market sales. After these transactions, she directly held 51,748 common shares.